These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23940110)

  • 1. A novel IL2RG mutation presenting with atypical T(-)B(+)NK+ phenotype: rapid elucidation of NK cell origin.
    Estévez OA; Ortega C; Fernández S; Aguado R; Rumbao J; Perez-Navero J; Santamaría M
    Pediatr Blood Cancer; 2014 Jan; 61(1):178-9. PubMed ID: 23940110
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel common gamma chain mutation in a Chinese family with X-linked severe combined immunodeficiency (X-SCID; T(-)NK(-)B(+)).
    Tan W; Yu S; Lei J; Wu B; Wu C
    Immunogenetics; 2015 Nov; 67(11-12):629-39. PubMed ID: 26409833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel IL2RG Mutation Causes Leaky TLOWB+NK+ SCID With Nodular Regenerative Hyperplasia and Normal IL-15 STAT5 Phosphorylation.
    Neves JF; Martins C; Cordeiro AI; Neves C; Plagnol V; Curtis J; Fabre M; Bibi S; Borrego LM; Moshous D; Nejentsev S; Gilmour K
    J Pediatr Hematol Oncol; 2019 May; 41(4):328-333. PubMed ID: 29939941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A synonymous splice site mutation in IL2RG gene causes late-onset combined immunodeficiency.
    Yamashita M; Wakatsuki R; Kato T; Okano T; Yamanishi S; Mayumi N; Tanaka M; Ogura Y; Kanegane H; Nonoyama S; Imai K; Morio T
    Int J Hematol; 2019 May; 109(5):603-611. PubMed ID: 30850927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with T⁺/low NK⁺ IL-2 receptor γ chain deficiency have differentially-impaired cytokine signaling resulting in severe combined immunodeficiency.
    Fuchs S; Rensing-Ehl A; Erlacher M; Vraetz T; Hartjes L; Janda A; Rizzi M; Lorenz MR; Gilmour K; de Saint-Basile G; Roifman CM; Cheuk S; Gennery A; Thrasher AJ; Fuchs I; Schwarz K; Speckmann C; Ehl S
    Eur J Immunol; 2014 Oct; 44(10):3129-40. PubMed ID: 25042067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel splice-site mutation in the common gamma chain (gammac) gene IL2RG results in X-linked severe combined immunodeficiency with an atypical NK+ phenotype.
    Ginn SL; Smyth C; Wong M; Bennetts B; Rowe PB; Alexander IE
    Hum Mutat; 2004 May; 23(5):522-3. PubMed ID: 15108287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel deletion mutation in IL2RG gene results in X-linked severe combined immunodeficiency with an atypical phenotype.
    Mou W; He J; Chen X; Zhang H; Ren X; Wu X; Ni X; Xu B; Gui J
    Immunogenetics; 2017 Jan; 69(1):29-38. PubMed ID: 27566612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Hemizygous IL2RG p.(Pro58Ser) Mutation Impairs IL-2 Receptor Complex Expression on Lymphocytes Causing X-Linked Combined Immunodeficiency.
    Tuovinen EA; Grönholm J; Öhman T; Pöysti S; Toivonen R; Kreutzman A; Heiskanen K; Trotta L; Toiviainen-Salo S; Routes JM; Verbsky J; Mustjoki S; Saarela J; Kere J; Varjosalo M; Hänninen A; Seppänen MRJ
    J Clin Immunol; 2020 Apr; 40(3):503-514. PubMed ID: 32072341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial T cell defects and expanded CD56
    Cifaldi C; Cotugno N; Di Cesare S; Giliani S; Di Matteo G; Amodio D; Piano Mortari E; Chiriaco M; Buonsenso D; Zangari P; Pagliara D; Gaspari S; Carsetti R; Palma P; Finocchi A; Locatelli F; Rossi P; Doria M; Cancrini C
    J Leukoc Biol; 2020 Aug; 108(2):739-748. PubMed ID: 32392633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73: 147-157. 1993.
    Noguchi M; Yi H; Rosenblatt HM; Filipovich AH; Adelstein S; Modi WS; McBride OW; Leonard WJ
    J Immunol; 2008 Nov; 181(9):5817-27. PubMed ID: 18941169
    [No Abstract]   [Full Text] [Related]  

  • 11. Detection of T lymphocytes with a second-site mutation in skin lesions of atypical X-linked severe combined immunodeficiency mimicking Omenn syndrome.
    Wada T; Yasui M; Toma T; Nakayama Y; Nishida M; Shimizu M; Okajima M; Kasahara Y; Koizumi S; Inoue M; Kawa K; Yachie A
    Blood; 2008 Sep; 112(5):1872-5. PubMed ID: 18559672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Mutations in the IL2RG Gene in 2 Asian Infants With X-linked Severe Combined Immunodeficiency.
    Hara Y; Kobayashi N; Maruyama Y; Motobayashi M; Shigemura T; Ohara O; Agematsu K; Koike K
    J Investig Allergol Clin Immunol; 2015; 25(4):313-5. PubMed ID: 26310054
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model.
    Alzubi J; Pallant C; Mussolino C; Howe SJ; Thrasher AJ; Cathomen T
    Sci Rep; 2017 Sep; 7(1):12475. PubMed ID: 28963568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutation analyses and prenatal diagnosis in two families of X linked severe combined immunodeficiency caused by IL2RG gene novel mutation].
    Kong X; Liu N; Xu X; Wu Q; Zhao Z; Bai Q; Meng J
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(16):1227-31. PubMed ID: 24924886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immunologic consequences of a somatic reversion in a patient with X-linked severe combined immunodeficiency.
    Speckmann C; Pannicke U; Wiech E; Schwarz K; Fisch P; Friedrich W; Niehues T; Gilmour K; Buiting K; Schlesier M; Eibel H; Rohr J; Superti-Furga A; Gross-Wieltsch U; Ehl S
    Blood; 2008 Nov; 112(10):4090-7. PubMed ID: 18728247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T
    Stepensky P; Keller B; Shamriz O; von Spee-Mayer C; Friedmann D; Shadur B; Unger S; Fuchs S; NaserEddin A; Rumman N; Amro S; Molho Pessach V; Abuzaitoun O; Somech R; Elpeleg O; Ehl S; Warnatz K
    J Clin Immunol; 2018 May; 38(4):527-536. PubMed ID: 29948574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Clinical Phenotypes in 2 Siblings With X-Linked Severe Combined Immunodeficiency.
    Wada T; Toma T ; Yasui M; Inoue M; Kawa K; Imai K; Morio T; Yachie A
    J Investig Allergol Clin Immunol; 2016; 26(1):63-5. PubMed ID: 27012023
    [No Abstract]   [Full Text] [Related]  

  • 18. Somatic Reversion of a Novel
    Hou Y; Gratz HP; Ureña-Bailén G; Gratz PG; Schilbach-Stückle K; Renno T; Güngör D; Mader DA; Malenke E; Antony JS; Handgretinger R; Mezger M
    Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.
    Mamcarz E; Zhou S; Lockey T; Abdelsamed H; Cross SJ; Kang G; Ma Z; Condori J; Dowdy J; Triplett B; Li C; Maron G; Aldave Becerra JC; Church JA; Dokmeci E; Love JT; da Matta Ain AC; van der Watt H; Tang X; Janssen W; Ryu BY; De Ravin SS; Weiss MJ; Youngblood B; Long-Boyle JR; Gottschalk S; Meagher MM; Malech HL; Puck JM; Cowan MJ; Sorrentino BP
    N Engl J Med; 2019 Apr; 380(16):1525-1534. PubMed ID: 30995372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IL-2RG R328X nonsense mutation allows partial STAT-5 phosphorylation and defines a critical region involved in the leaky-SCID phenotype.
    Arcas-García A; Garcia-Prat M; Magallón-Lorenz M; Martín-Nalda A; Drechsel O; Ossowski S; Alonso L; Rivière JG; Soler-Palacín P; Colobran R; Sayós J; Martínez-Gallo M; Franco-Jarava C
    Clin Exp Immunol; 2020 Apr; 200(1):61-72. PubMed ID: 31799703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.